Applied Clinical Trials-10-01-2018

Applied Clinical Trials
Feature Article

October 01, 2018

In this article, Crissy MacDonald reviews the key changes in ICH E6 (R2), discuss the challenges organizations are facing, and present actionable recommendations for organizations to implement now.

Applied Clinical Trials

A new report on EU's digital health strategy also calls for closer coordination of national HTA arrangements-but both policy initiatives couldn't be more different.

Applied Clinical Trials

FDA is joining with other federal health agencies and the biomedical community to advance science, regulatory policies, and reimbursement strategies to combat the need for new medicines for infectious diseases.

Applied Clinical Trials

Success in developing targeted medicines means companies need a companion diagnostic strategy, the expertise, and more.

Applied Clinical Trials

Forming strategic alliances and collaborating to optimize study design can significantly improve pediatric drug development.

Applied Clinical Trials

How mapping patients’ health journeys can drive a deeper understanding of their experiences and motivations.

Applied Clinical Trials

Q&A highlights one such example of M&A movement in the CRO space toward mid-sized companies focused in specific disease indications.

Applied Clinical Trials

A multitude of data sources leaves clinical data management systems in catch-up mode-and researcher dizzy trying to follow the data- but there is hope for simplification on the horizon.

Applied Clinical Trials
A Closing Thought

October 01, 2018

Key tips and resources to help evade the common traps of market landscaping-today an increasingly high-stakes and comprehensive task during clinical development.

Issue PDF
Applied Clinical Trials

October 01, 2018

Click the title above to open the Applied Clinical Trials October 2018 issue in an interactive PDF format.